The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Screening of CHEK2 and TP53 p.R337H germ-line mutations in high-risk patients for hereditary breast and ovarian cancer from northeast of Brazil.
Ivana Lucia Oliveira Nascimento
No relevant relationships to disclose
Gabriela Espirito Santo Felix
No relevant relationships to disclose
Taisa Manuela Bonfim Machado-Lopes
No relevant relationships to disclose
Thais Bomfim
No relevant relationships to disclose
Maura Romeo
No relevant relationships to disclose
Betania Toralles
No relevant relationships to disclose
Bernardo Garicochea
No relevant relationships to disclose
Roberto Meyer
No relevant relationships to disclose
Kiyoko Abe-Sandes
No relevant relationships to disclose